A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia

Clinical trial NCT03538041 · COMPLETED

Trial details

NCT number: NCT03538041
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autoimmune Hemolytic Anemia

Start date: 2018-11-21
Primary completion: 2021-08-05
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.